Literature DB >> 24562719

Interchangeability of 28-joint disease activity scores using the erythrocyte sedimentation rate or the C-reactive protein as inflammatory marker.

Liseth Siemons1, Harald E Vonkeman, Peter M ten Klooster, Piet L C M van Riel, Mart A F J van de Laar.   

Abstract

This paper aims to examine the interchangeability of the disease activity score in 28 joints (DAS28)-erythrocyte sedimentation rate (ESR) and DAS28-CRP scores in a diverse sample of rheumatoid arthritis (RA) patients and to evaluate generalizability over gender, age, and disease duration. A sample of 682 patients was drawn from the DREAM registry. Agreement between the two DAS28 scores was analyzed using the intraclass correlation coefficient (ICC), Bland Altman plots, and a matrix of classification agreement over DAS28 disease activity categories. Despite a strong linear correlation between the DAS28 scores and a high ICC value of 0.931, a considerable lack of individual agreement could be observed, with Bland-Altman 95% limits of agreement ranging between -0.85 and +1.25 points. On average, DAS28-CRP scores were 0.20 points lower than DAS28-ESR scores, and data stratification on age and gender showed that this systematic bias was most severe in older women (0.39 points). The overall classification agreement across DAS28 categories was 76.69%, with the agreement being lowest (35.37%) in the low disease activity group. Patients were more easily classified as being in remission when using the DAS28-CRP measure. DAS28-ESR and DAS28-CRP scores are not interchangeable within individuals. The DAS28-CRP tends to yield lower values of disease activity than the DAS28-ESR, resulting in substantial classification differences.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24562719     DOI: 10.1007/s10067-014-2538-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

1.  Twenty eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rate.

Authors:  T Skogh; D Gustafsson; M Kjellberg; M Husberg
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

2.  Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.

Authors:  P Emery; R Van Vollenhoven; M Ostergaard; E Choy; B Combe; W Graninger; K Krueger; M Matucci-Cerinic; F Navarro; P van Riel; L Settas; S Steinfeld
Journal:  Ann Rheum Dis       Date:  2009-04       Impact factor: 19.103

3.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

4.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

5.  Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values.

Authors:  Eisuke Inoue; Hisashi Yamanaka; Masako Hara; Taisuke Tomatsu; Naoyuki Kamatani
Journal:  Ann Rheum Dis       Date:  2006-08-22       Impact factor: 19.103

6.  Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.

Authors:  F Wolfe
Journal:  J Rheumatol       Date:  1997-08       Impact factor: 4.666

7.  Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis.

Authors:  Cynthia S Crowson; Mahboob U Rahman; Eric L Matteson
Journal:  J Rheumatol       Date:  2009-06-16       Impact factor: 4.666

8.  Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis.

Authors:  B J Radovits; J Fransen; P L C M van Riel; R F J M Laan
Journal:  Ann Rheum Dis       Date:  2007-10-27       Impact factor: 19.103

9.  Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.

Authors:  Toshihiro Matsui; Yoshiaki Kuga; Atsushi Kaneko; Jinju Nishino; Yoshito Eto; Noriyuki Chiba; Masayuki Yasuda; Koichiro Saisho; Kota Shimada; Shigeto Tohma
Journal:  Ann Rheum Dis       Date:  2007-03-16       Impact factor: 19.103

10.  Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate.

Authors:  G Wells; J-C Becker; J Teng; M Dougados; M Schiff; J Smolen; D Aletaha; P L C M van Riel
Journal:  Ann Rheum Dis       Date:  2008-05-19       Impact factor: 19.103

View more
  11 in total

1.  Comparison between different disease activity scores in rheumatoid arthritis: an Egyptian multicenter study.

Authors:  M Eissa; A El Shafey; M Hammad
Journal:  Clin Rheumatol       Date:  2017-05-22       Impact factor: 2.980

2.  Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis.

Authors:  Carson Maynard; Ted R Mikuls; Grant W Cannon; Bryant R England; Philip G Conaghan; Mikkel Østergaard; Daniel G Baker; Gail Kerr; Michael D George; Jennifer L Barton; Joshua F Baker
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-03       Impact factor: 4.794

3.  What can hand sonography and nerve conduction velocity disclose regarding hand dysfunction in rheumatoid arthritis patients?

Authors:  E A Abda; M M Hassanien; E Abdelrazek; S A Mahran
Journal:  Z Rheumatol       Date:  2020-10-02       Impact factor: 1.372

4.  Validity and Agreement between the 28-Joint Disease Activity Score Based on C-Reactive Protein and Erythrocyte Sedimentation Rate in Patients with Rheumatoid Arthritis.

Authors:  Louise Nielung; Robin Christensen; Bente Danneskiold-Samsøe; Henning Bliddal; Christian Cato Holm; Karen Ellegaard; Hanne Slott Jensen; Else Marie Bartels
Journal:  Arthritis       Date:  2015-01-14

5.  Comparison of the Japanese Orthopaedic Association (JOA) score and modified JOA (mJOA) score for the assessment of cervical myelopathy: a multicenter observational study.

Authors:  So Kato; Yasushi Oshima; Hiroyuki Oka; Hirotaka Chikuda; Yujiro Takeshita; Kota Miyoshi; Naohiro Kawamura; Kazuhiro Masuda; Junichi Kunogi; Rentaro Okazaki; Seiichi Azuma; Nobuhiro Hara; Sakae Tanaka; Katsushi Takeshita
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

6.  The Utility and Limitations of CRP, ESR and DAS28-CRP in Appraising Disease Activity in Rheumatoid Arthritis.

Authors:  Carl K Orr; Aurelie Najm; Francis Young; Trudy McGarry; Monika Biniecka; Ursula Fearon; Douglas J Veale
Journal:  Front Med (Lausanne)       Date:  2018-08-03

7.  Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis.

Authors:  Elizabeth M A Hensor; Paul McKeigue; Stephanie F Ling; Marco Colombo; Jennifer H Barrett; Jackie L Nam; Jane Freeston; Maya H Buch; Athina Spiliopoulou; Felix Agakov; Stephen Kelly; Myles J Lewis; Suzanne M M Verstappen; Alexander J MacGregor; Sebastien Viatte; Anne Barton; Costantino Pitzalis; Paul Emery; Philip G Conaghan; Ann W Morgan
Journal:  Rheumatology (Oxford)       Date:  2019-03-01       Impact factor: 7.580

8.  ¹H-NMR-Based Metabolomic Study for Identifying Serum Profiles Associated with the Response to Etanercept in Patients with Rheumatoid Arthritis.

Authors:  Roberta Priori; Luca Casadei; Mariacristina Valerio; Rossana Scrivo; Guido Valesini; Cesare Manetti
Journal:  PLoS One       Date:  2015-11-11       Impact factor: 3.240

9.  Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis.

Authors:  Philip D H Hamann; Gavin Shaddick; Kimme Hyrich; Amelia Green; Neil McHugh; John D Pauling
Journal:  Rheumatology (Oxford)       Date:  2019-05-01       Impact factor: 7.580

10.  Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.

Authors:  Peter M Ten Klooster; Letty G A Versteeg; Martijn A H Oude Voshaar; Inmaculada de la Torre; Francesco De Leonardis; Walid Fakhouri; Liliana Zaremba-Pechmann; Mart van de Laar
Journal:  Arthritis Res Ther       Date:  2019-11-12       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.